Clincosm LogoSign in Get a demo

brca2 mutation carrier

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ Trial in Los Angeles (dietary supplement, other,

Active, not recruiting
  • BRCA1 Mutation Carrier
  • +8 more
  • soy isoflavones
  • +7 more
  • Los Angeles, California
    University of Southern California
Nov 11, 2021

BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma In Situ Trial in West Hollywood, Chicago, New York

Unknown status
  • BRCA1 Mutation Carrier
  • +8 more
  • Telapristone Acetate
  • +3 more
  • West Hollywood, California
  • +2 more
Aug 16, 2019

Basal-Like Breast Carcinoma, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier Trial in United States (Laboratory Biomarker

Completed
  • Basal-Like Breast Carcinoma
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +6 more
Jun 28, 2018

Lysophosphatidic Acid Assay in Ovarian Cancer or Who Are at Risk

Completed
  • brca1 Mutation Carrier
  • +2 more
  • Biomarker LPA and HE4
  • Providence, Rhode Island
    Women and Infants Hospital of Rhode Island
Jan 3, 2018

Women Who Are BRCA1/BRCA2 Mutation Carriers

Withdrawn
  • BRCA1 Mutation Carrier
  • +2 more
  • Laboratory Biomarker Analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 11, 2017

brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer Trial in United Kingdom (drug, genetic, other)

Completed
  • brca1 Mutation Carrier
  • +3 more
  • rucaparib (CO-338; formally AG-014699 or PF-01367338)
  • +6 more
  • Birmingham, England, United Kingdom
  • +6 more
May 23, 2016

Atypical Ductal Breast Hyperplasia, Atypical Lobular Breast Hyperplasia, BRCA1 Mutation Carrier Trial in Seattle (counseling

Completed
  • Atypical Ductal Breast Hyperplasia
  • +5 more
  • counseling intervention
  • +4 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jan 15, 2016

Adult Solid Tumor, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier Trial in Hershey, Pittsburgh (Diagnostic Laboratory Biomarker

Completed
  • Adult Solid Neoplasm
  • +2 more
  • Diagnostic Laboratory Biomarker Analysis
  • +3 more
  • Hershey, Pennsylvania
  • +3 more
Jun 30, 2015

Adult Solid Tumor, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier Trial in United States (Carboplatin, Laboratory Biomarker

Completed
  • Adult Solid Neoplasm
  • +3 more
  • Duarte, California
  • +6 more
May 21, 2015

Adenocarcinoma of the Pancreas, Adenocarcinoma of the Stomach, BRCA1 Mutation Carrier Trial in Madison (veliparib, capecitabine,

Terminated
  • Adenocarcinoma of the Pancreas
  • +25 more
  • Madison, Wisconsin
    University of Wisconsin Hospital and Clinics
Apr 1, 2014

brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer Trial in Worldwide (carboplatin, docetaxel)

Completed
  • brca1 Mutation Carrier
  • +3 more
  • Parkville, Victoria, Australia
  • +24 more
Aug 23, 2013

brca1 Mutation Carrier, brca2 Mutation Carrier, Ovarian Cancer Trial in Birmingham (celecoxib, oophorectomy)

Withdrawn
  • brca1 Mutation Carrier
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham Comprehensive Cancer Center
Aug 21, 2013

Women Who Are BRCA1/BRCA2 Mutation Carriers

Unknown status
  • brca1 Mutation Carrier
  • +2 more
  • DNA analysis
  • +4 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Mar 22, 2011

brca1 Mutation Carrier, brca2 Mutation Carrier, Ovarian Cancer Trial in Tucson (fenretinide)

Completed
  • brca1 Mutation Carrier
  • +2 more
  • Tucson, Arizona
    Arizona Cancer Center at University of Arizona Health Sciences C
Mar 23, 2010